SCHEMBL1259096

SCHEMBL1259096

COc1ccc(N=C2SC(=Cc3cc(OC)c(O)c(OC)c3)C(=O)N2c2ccccc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 4/20 0.74
▸ S1PR1 P21453 8/20 0.59
▸ S1PR3 Q99500 8/20 0.59
▸ MEN1 O00255 6/20 0.58
▸ KMT2A Q03164 6/20 0.58
▸ ALDH1A1 P00352 4/20 0.58
▸ MAPT P10636 4/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ LMNA P02545 1/20 0.56
▸ GAA P10253 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ MCL1 Q07820 1/20 0.51
▸ PSMD14 O00487 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ PTPN2 P17706 1/20 0.49
▸ PTPN1 P18031 1/20 0.49
▸ ACP1 P24666 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259094 1.00 FAAH (0.74) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL12013888 0.97 FAAH (0.72) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL12013735 0.95 FAAH (0.81) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL12013727 0.89 FAAH (0.69) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL1259408 0.89 FAAH (0.69) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL1259405 0.89 FAAH (0.69) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL17295326 0.88 FAAH (0.84) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL17295325 0.88 FAAH (0.84) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL17302128 0.88 FAAH (0.89) FAAHS1PR1S1PR3MEN1KMT2A
SCHEMBL12013229 0.87 FAAH (0.72) FAAHS1PR1S1PR3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252940-B2 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection UNIVERSITY OF WASHINGTON (US) 2012-08-28 — — US disclosed
US-20110039849-A1 5-SUBSTITUTED-2-IMINO-THIAZOLIDINONE COMPOUNDS AND THEIR USE AS INHIBITORS OF BACTERIAL INFECTION UNIVERSITY OF WASHINGTON (US) 2011-02-17 — — US disclosed
WO-2009137133-A2 5-SUBSTITUTED-2-IMINO-THIAZOLIDINONE COMPOUNDS AND THEIR USE AS INHIBITORS OF BACTERIAL INFECTION UNIVERSITY OF WASHINGTON (US) 2009-11-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039849-A1 5-SUBSTITUTED-2-IMINO-THIAZOLIDINONE COMPOUNDS AND THEIR USE AS INHIBITORS OF BACTERIAL INFECTION IRF3, GDI2, TLR5 FAAH 4487/4885S1PR1 4789/4885S1PR3 4471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback